HSBC Holdings’s QIAGEN NV QGENF Stock Holding History

HSBC Holdings’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,000	Closed	-$45K	–	2277
2016 Q1	$45K	Hold	2,000	–	–	﹤0.01%	2049
2015 Q4	$55K	Buy	+2,000	New	+$55K	﹤0.01%	2187
2015 Q3	–	Sell	-234,720	Closed	-$5.82M	–	2326
2015 Q2	$5.82M	Buy	+234,720	New	+$5.82M	0.01%	782
2014 Q4	–	Sell	-22,500	Closed	-$511K	–	1892
2014 Q3	$511K	Buy	+22,500	New	+$511K	﹤0.01%	1460

Other funds holding QGENF

BJCM

Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return

Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

HSBC Holdings's QGENF Position: Q1 2017 in Review

HSBC Holdings sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 504,067 shares — an estimated $14.2M sold.

HSBC Holdings first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $20.3M in Q1 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

HSBC Holdings reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
HSBC Holdings sold 504,067 QIAGEN NV shares in Q1 2017, an estimated $14.2M.
HSBC Holdings first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
HSBC Holdings's QIAGEN NV position peaked at $20.3M in Q1 2015.
6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on HSBC Holdings's 13F filing for Q1 2017, filed 15 May 2017.